Found: 39
Select item for more details and to access through your institution.
Diabetic Foot Ulcers and Epidermal Growth Factor: Revisiting the Local Delivery Route for a Successful Outcome.
- Published in:
- BioMed Research International, 2017, v. 2017, p. 1, doi. 10.1155/2017/2923759
- By:
- Publication type:
- Article
Diagnostic Accuracy of Blood-Based Biomarker Panels: A Systematic Review.
- Published in:
- Frontiers in Aging Neuroscience, 2022, v. 14, p. 1, doi. 10.3389/fnagi.2022.683689
- By:
- Publication type:
- Article
Cell-Free Filtrates (CFF) as Vectors of a Transmissible Pathologic Tissue Memory Code: A Hypothetical and Narrative Review.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 19, p. 11575, doi. 10.3390/ijms231911575
- By:
- Publication type:
- Article
Intralesional Infiltrations of Arteriosclerotic Tissue Cells-Free Filtrate Reproduce Vascular Pathology in Healthy Recipient Rats.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 3, p. 1511, doi. 10.3390/ijms23031511
- By:
- Publication type:
- Article
Intranasal HBsAg/HBcAg-Containing Vaccine Induces Neutralizing Anti-HBs Production in Hepatitis B Vaccine Non-Responders.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1479, doi. 10.3390/vaccines11091479
- By:
- Publication type:
- Article
Innovative Therapies Targeting the Virus and the Host for Treating Chronic Hepatitis B Virus Infection: From Bench to Bedside.
- Published in:
- Vaccines, 2022, v. 10, n. 5, p. 746, doi. 10.3390/vaccines10050746
- By:
- Publication type:
- Article
The Safety and Efficacy of a Therapeutic Vaccine for Chronic Hepatitis B: A Follow-Up Study of Phase III Clinical Trial.
- Published in:
- Vaccines, 2022, v. 10, n. 1, p. 45, doi. 10.3390/vaccines10010045
- By:
- Publication type:
- Article
Anti-inflammatory mechanisms and pharmacological actions of phycocyanobilin in a mouse model of experimental autoimmune encephalomyelitis: A therapeutic promise for multiple sclerosis.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1036200
- By:
- Publication type:
- Article
Combination therapy of Epidermal Growth Factor and Growth Hormone-Releasing Hexapeptide in acute ischemic stroke: a phase I/II non-blinded, randomized clinical trial.
- Published in:
- Frontiers in Neurology, 2024, p. 1, doi. 10.3389/fneur.2024.1303402
- By:
- Publication type:
- Article
Scalable Bio Marker Combinations for Early Stroke Diagnosis: A Systematic Review.
- Published in:
- Frontiers in Neurology, 2021, v. 12, p. 1, doi. 10.3389/fneur.2021.638693
- By:
- Publication type:
- Article
Insulin Resistance at the Crossroad of Alzheimer Disease Pathology: A Review.
- Published in:
- Frontiers in Endocrinology, 2020, v. 11, p. N.PAG, doi. 10.3389/fendo.2020.560375
- By:
- Publication type:
- Article
Cellular Senescence as the Pathogenic Hub of Diabetes-Related Wound Chronicity.
- Published in:
- Frontiers in Endocrinology, 2020, v. 11, p. N.PAG, doi. 10.3389/fendo.2020.573032
- By:
- Publication type:
- Article
Enhancement of the inhibitory effect of an IL-15 antagonist peptide by alanine scanning.
- Published in:
- Journal of Peptide Science, 2012, v. 18, n. 1, p. 25, doi. 10.1002/psc.1411
- By:
- Publication type:
- Article
The effects of Phycocyanobilin on experimental arthritis involve the reduction in nociception and synovial neutrophil infiltration, inhibition of cytokine production, and modulation of the neuronal proteome.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1227268
- By:
- Publication type:
- Article
A peptide derived from HSP60 reduces proinflammatory cytokines and soluble mediators: a therapeutic approach to inflammation.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1162739
- By:
- Publication type:
- Article
Synthetic Growth Hormone-Releasing Peptides (GHRPs): A Historical Appraisal of the Evidences Supporting Their Cytoprotective Effects.
- Published in:
- Clinical Medicine Insights: Cardiology, 2017, v. 11, p. 1, doi. 10.1177/1179546817694558
- By:
- Publication type:
- Article
Contribution of human recombinant Interferon-Alpha 2b treatment in symptomatic and asymptomatic patients with SARS-CoV-2 virus infection.
- Published in:
- Revista Habanera de Ciencias Médicas, 2022, v. 21, n. 4, p. 1
- By:
- Publication type:
- Article
Reliability of CNEURO hyssops for sample collection in the SARS-CoV-2 diagnosis.
- Published in:
- Revista Habanera de Ciencias Médicas, 2022, v. 21, n. 1, p. 1
- By:
- Publication type:
- Article
Comparison between nasopharyngeal swabs and saliva as reliable specimens for the diagnosis of SARS-CoV-2.
- Published in:
- Revista Habanera de Ciencias Médicas, 2021, v. 20, n. 3, p. 1
- By:
- Publication type:
- Article
Evidence of SARS-CoV-2 infection in postmortem lung, kidney, and liver samples, revealing cellular targets involved in COVID-19 pathogenesis.
- Published in:
- Archives of Virology, 2023, v. 168, n. 3, p. 1, doi. 10.1007/s00705-023-05711-y
- By:
- Publication type:
- Article
Sustained Antiviral and Liver Protection by a Nasal Therapeutic Vaccine (NASVAC, Containing Both HBsAg and HBcAg) in Patients with Chronic Hepatitis B: 2-Year Follow-Up of Phase III Clinical Trial.
- Published in:
- Pathogens, 2021, v. 10, n. 11, p. 1440, doi. 10.3390/pathogens10111440
- By:
- Publication type:
- Article
Revisiting Pleiotropic Effects of Type I Interferons: Rationale for Its Prophylactic and Therapeutic Use Against SARS-CoV-2.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2021.655528
- By:
- Publication type:
- Article
The Nucleocapsid Protein of SARS-CoV-2, Combined with ODN-39M, Is a Potential Component for an Intranasal Bivalent Vaccine with Broader Functionality.
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 3, p. 418, doi. 10.3390/v16030418
- By:
- Publication type:
- Article
Wound Chronicity, Impaired Immunity and Infection in Diabetic Patients.
- Published in:
- MEDICC Review, 2022, v. 24, n. 1, p. 44
- By:
- Publication type:
- Article
Epidermal Growth Factor in Healing Diabetic Foot Ulcers: From Gene Expression to Tissue Healing and Systemic Biomarker Circulation.
- Published in:
- MEDICC Review, 2020, v. 22, n. 3, p. 24, doi. 10.37757/MR2020.V22.N3.7
- By:
- Publication type:
- Article
Systemic translation of locally infiltrated epidermal growth factor in diabetic lower extremity wounds.
- Published in:
- International Wound Journal, 2019, v. 16, n. 6, p. 1294, doi. 10.1111/iwj.13189
- By:
- Publication type:
- Article
Epidermal growth factor in clinical practice – a review of its biological actions, clinical indications and safety implications.
- Published in:
- International Wound Journal, 2009, v. 6, n. 5, p. 331, doi. 10.1111/j.1742-481X.2009.00622.x
- By:
- Publication type:
- Article
The pro-inflammatory environment in recalcitrant diabetic foot wounds.
- Published in:
- International Wound Journal, 2008, v. 5, n. 4, p. 530, doi. 10.1111/j.1742-481X.2008.00457.x
- By:
- Publication type:
- Article
Development of Therapy Based on the Exploration of Biological Events Underlying the Pathogenetic Mechanisms of Chronic Hepatitis B Infection.
- Published in:
- Biomedicines, 2023, v. 11, n. 7, p. 1944, doi. 10.3390/biomedicines11071944
- By:
- Publication type:
- Article
Jusvinza, an anti-inflammatory drug derived from the human heat-shock protein 60, for critically ill COVID-19 patients. An observational study.
- Published in:
- PLoS ONE, 2023, v. 17, n. 2, p. 1, doi. 10.1371/journal.pone.0281111
- By:
- Publication type:
- Article
Carcinogenic effect of human tumor-derived cell-free filtrates in nude mice.
- Published in:
- Frontiers in Molecular Biosciences, 2024, p. 01, doi. 10.3389/fmolb.2024.1361377
- By:
- Publication type:
- Article
Contrasting Timing of Virological Relapse After Discontinuation of Tenofovir or Entecavir in Hepatitis B e Antigen-Negative Patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Epidermal Growth Factor Intralesional Delivery in Chronic Wounds: The Pioneer and Standalone Technique for Reversing Wound Chronicity and Promoting Sustainable Healing †.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 20, p. 10883, doi. 10.3390/ijms252010883
- By:
- Publication type:
- Article
Endogenous Biological Drivers in Diabetic Lower Limb Wounds Recurrence: Hypothetical Reflections.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 12, p. 10170, doi. 10.3390/ijms241210170
- By:
- Publication type:
- Article
Differential expression of pro-inflammatory cytokines IL-15Ralpha, IL-15, IL-6 and TNFalpha in synovial fluid from Rheumatoid arthritis patients.
- Published in:
- BMC Musculoskeletal Disorders, 2015, v. 16, n. 1, p. 1, doi. 10.1186/s12891-015-0516-3
- By:
- Publication type:
- Article
The influence of different peptide combinations to increase the immunogenicity of the Gonadotrophin Releasing Hormone Vaccine for prostate cancer treatment.
- Published in:
- Journal of Experimental Therapeutics & Oncology, 2017, v. 12, n. 2, p. 87
- By:
- Publication type:
- Article
Glucose Toxic Effects on Granulation Tissue Productive Cells: The Diabetics' Impaired Healing.
- Published in:
- BioMed Research International, 2013, v. 2013, p. 1, doi. 10.1155/2013/256043
- By:
- Publication type:
- Article
Growth hormone releasing peptide-6 (GHRP-6) prevents doxorubicin-induced myocardial and extra-myocardial damages by activating prosurvival mechanisms.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1402138
- By:
- Publication type:
- Article
Proinflammatory Soluble Interleukin-15 Receptor Alpha Is Increased in Rheumatoid Arthritis.
- Published in:
- Arthritis (20901984), 2012, p. 1, doi. 10.1155/2012/943156
- By:
- Publication type:
- Article